Brazil's National Health Surveillance Agency (Anvisa) has approved the use of the drug donanemabe to slow the progression of Alzheimer's disease in patients with mild cognitive impairment and mild ...
RFID Journal LIVE! 2023 will feature end-user companies discussing RFID’s use in various industries, including pharmaceuticals, as well as exhibitors offering tagging solutions for multiple ...
ANVISA did not stipulate what categories of products the mechanism would be available for. The new rules, which have yet to be published, will also more precisely define risk categories, study phases, ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Akums Drugs & Pharmaceuticals Ltd., India’s largest contract manufacturing pharmaceutical company, announced that its sterile manufacturing plant has received the prestigious Good Manufacturing ...
To help drug manufacturers comply with the technical requirements of RCD 753/2022 and other related standards regarding proof of a drug’s safety and efficacy, Brazil’s Anvisa issued three new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results